| Unique ID issued by UMIN | UMIN000059490 |
|---|---|
| Receipt number | R000068034 |
| Scientific Title | Effects of Alkaline Ionized Water Gargling on Streptococcus mutans Levels and Salivary Properties |
| Date of disclosure of the study information | 2025/10/21 |
| Last modified on | 2025/10/21 16:25:07 |
A Study on the Effects of Gargling with Alkaline Ionized Water on Salivary Levels of Caries-Causing Bacteria
Alkaline Ionized Water - Caries Bacteria Study
Effects of Alkaline Ionized Water Gargling on Streptococcus mutans Levels and Salivary Properties
Alkaline Ionized Water - Streptococcus Mutans Study
| Japan |
Dental caries
| Dental medicine |
Others
NO
To evaluate the effect of gargling with alkaline ionized water on the oral environment of healthy adults, with a particular focus on changes in salivary Streptococcus mutans levels.
Safety
Confirmatory
Not applicable
Change in salivary Streptococcus mutans levels before and after a 30-day gargling intervention with alkaline ionized water.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Food |
Participants will gargle with alkaline ionized water three times daily, immediately after each meal (breakfast, lunch, and dinner), for a total of 30 consecutive days. Each gargling session will last approximately 30 seconds. The total daily amount of alkaline ionized water used is 500 milliliters.
| 20 | years-old | <= |
| 70 | years-old | >= |
Male and Female
Twenty functional teeth or more.
Able to provide written informed consent.
Known allergy or hypersensitivity to any mineral components in alkaline ionized water.
Medical conditions contraindicating gargling (e.g., dysphagia or severe oral dysfunction).
Ongoing dental treatment for active caries or other oral diseases that may affect study assessments.
Concurrent participation in other oral health programs or clinical studies that may influence the results of this study.
30
| 1st name | Tsutomu |
| Middle name | |
| Last name | Sato |
Tokai University School of Medicine
Division of Basic Medical Science,
259-1193
143 Shimokasuya, Isehara, Kanagawa, Japan
+81-463-93-1121(2513)
b-sato2@tokai.ac.jp
| 1st name | Megumi |
| Middle name | |
| Last name | Suzuki |
The Nippon Dental University College at Tokyo
Department of Dental Hygiene
162-0815
2-3 Tsukudo-Hachiman, Shinjuku-ku, Tokyo
+81-3-3266-5063
megumi-t@tandai.ndu.ac.jp
Tokai University
Tsutomu Sato
Association of Alkaline Ionized Water Apparatus
Other
The Ethics Committee of Tsurumi University School of Dental Medicine
2-1-3 Tsurumi, Yokohama, Japan
+81-45-580-8205
kyoken@tsurumi-u.ac.jp
NO
| 2025 | Year | 10 | Month | 21 | Day |
Unpublished
30
The 30-day AIW mouth-rinsing intervention resulted in a statistically significant decrease in salivary S. mutans levels (P < 0.01; Wilcoxon signed-rank test). The median Dentocult SM score decreased from Score 2 to Score 1, and 70% of the participants showed a reduction in their S. mutans score category.
| 2025 | Year | 10 | Month | 21 | Day |
A total of 30 healthy adult volunteers (16 male, 14 female; mean age: 42.6 years; range: 24-66 years) were enrolled. All participants had at least 24 functional teeth.
Participants were first screened for eligibility and provided written informed consent. Baseline saliva samples were collected prior to the intervention. Each participant then performed gargling with alkaline ionized water three times daily after meals for 30 consecutive days. After the intervention period, saliva samples were collected again, and adherence records and adverse events were reviewed. The study was completed following final evaluations.
None.
Primary Outcome: Change in salivary Streptococcus mutans levels after a 30-day alkaline ionized water mouth-rinsing intervention.
Measurement method: Dentocult SM Strip Mutans kit (Orion Diagnostica, Finland), scored on a 4-point ordinal scale.
Results: 70% of participants (21/30) showed a reduction in score category. Median score decreased from Score 2 at baseline to Score 1 post-intervention. Wilcoxon signed-rank test showed a significant reduction (P < 0.01).
Plan to share individual participant data.
The individual participant data IPD collected during the clinical trial will not be publicly available due to patient privacy regulations and restrictions imposed by the Institutional Ethics Committees. However, de-identified data may be made available upon reasonable request to the Principal Investigator, provided that the request complies with ethical guidelines and institutional approval.
Completed
| 2017 | Year | 10 | Month | 20 | Day |
| 2017 | Year | 11 | Month | 28 | Day |
| 2018 | Year | 12 | Month | 01 | Day |
| 2024 | Year | 12 | Month | 13 | Day |
| 2025 | Year | 10 | Month | 21 | Day |
| 2025 | Year | 10 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068034
| Research Plan | |
|---|---|
| Registered date | File name |
| 2025/10/22 | Clinical protocol (AIW).pdf |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| 2025/10/22 | Data specification (AIW) ver. 2.pdf |
| Research case data | |
|---|---|
| Registered date | File name |
| 2025/10/22 | Data (AIW).xlsx |
Value
https://center6.umin.ac.jp/ice/68034